REGAIA - REGulatory AI Agents - The compliance podcast

About REGAIA - REGulatory AI Agents - The compliance podcast

REGAIA — REGulatory AI Agents The regulatory compliance industry is standing on a fault line. On February 3, 2026, a single AI plugin wiped $300 billion off the legal tech sector in one trading session. Medical devices, cosmetics, pharmaceuticals — every regulated industry built on document-heavy workflows, specialized knowledge, and information asymmetry faces the same structural disruption. REGAIA is the podcast that maps this transformation in real time. Each week, we break down how artificial intelligence agents — not chatbots, not search tools, but autonomous systems that plan, execute, and deliver regulatory workflows — are fundamentally changing how compliance gets done. From MDR dossier preparation to cosmetic safety assessments, from EU AI Act readiness to global market access across 70+ jurisdictions, REGAIA covers the technologies, strategies, and business models that will define the next era of regulated industries. This show is built for regulatory affairs directors, quality managers, compliance consultants, HealthTech and BeautyTech entrepreneurs, and anyone whose work depends on navigating the world's most complex regulatory frameworks. Whether you lead a team of fifty or run a solo consultancy, if regulation is your business, REGAIA is your competitive edge. What you will learn : How agentic AI differs from conversational AI — and why the distinction matters for regulated industries. What the Model Context Protocol (MCP) means for connecting AI to your regulatory data. Why configurable playbooks turn domain expertise into a scalable digital asset. How to architect an AI agent platform using the three-layer model. Where the market gaps are — and who is filling them. What the EU AI Act, MDR deadlines, and FDA reforms mean for AI adoption in 2026 and beyond. An original concept by Patrick de Carvalho (https://www.linkedin.com/in/patrickdecarvalho/). A Studio Je ne perds jamais production. Powered by 72h-podcast.com (https://72h-podcast.com). New episodes every week. regaia.eu #REGAIA #RegulatoryAI #AIAgents #RegTech #ComplianceAI Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

Publisher

Patrick DE CARVALHO

Category

business · science · technology

Language

en

Explicit

No

First episode

3 Feb 2026

Latest episode

8 Mar 2026

Latest episodes

7 episodes in the feed.

1. 

   8 Mar 2026

   The End of "One-Size-Fits-All": How AI and Biotech Are Hacking Your Biology

   Did you know there is a 70% chance the skincare you applied this morning is actively fighting your skin's natural ecosystem? 🧴🔬 The era of guessing your health and beauty routines based on generic demographic buckets or "skin types" is officially dead. Welcome to the age of hyper-personalized, real-time biological mapping. In this deep dive, we connect the dots between breakthrough French deep-tech startups (Biome Labs), the ambient AI reveals from CES 2026, and the biotech revolution happening at the InCosmetics Global Expo. We explore how a simple 5-minute retail swab can sequence your microbiome, and how ambient AI—from Samsung smart rings to office posture monitors—is passively tracking "weak signals" of cognitive decline and stress. But what happens to our privacy when devices map our every breath and keystroke? Discover how "Edge Computing" is saving our data, why precision fermentation is replacing resource extraction (saving 92% of emissions on hyaluronic acid), and how wearable robotics are actively rewiring stroke survivors' brains. 🎙️ Key Takeaways: The Microbiome Revolution (Biome Labs): Why 70% of cosmetics are thrown away, and how a 5-minute physical swab and a 5,000-genome AI database can harmonize your skin by feeding the "good" bacteria (S. epidermidis) and starving the bad (C. acnes). Ambient AI & Weak Signals: How the next generation of wearables (like the Samsung Galaxy Watch 8) passively detects early signs of dementia by analyzing the micro-hesitations in your typing speed and the rhythm of your gait. At-Home Clinical Labs (Mira Ultra 4): The end of random blood tests. How fluorescent technology tracks your master hormones (FSH, LH) in just 16 minutes from your bathroom. Privacy via Edge Computing: Why systems like Deep Care ISA (posture tracking) and Sonnaid (medical emergency audio detection) process data locally on the chip and overwrite it instantly, keeping your raw data out of the cloud. Neuroplasticity & Wearable Robotics: From the HyperShell X consumer exoskeleton to WimKids (pediatric assistive robots) and FinSTIM (implantable AI for Parkinson's)—how tech is moving from passive support to actively forcing the brain to rewire itself. Biotech vs. Ecological Collapse: Why strict EU regulations (EUDR, PFAS bans) are forcing the industry to abandon natural harvesting. Discover how Givaudan brews hyaluronic acid using programmed yeast, and how Swedish Algae Factory upcycles diatom shells into UV boosters. 💡 The Final Thought: If ambient AI and our environment become perfectly calibrated to smooth out every physical and chemical stressor before we even consciously feel them... how will our brains know when we are actually in danger? Are we actively engineering out our own human survival instincts? ⏱️ Chapter Markers: 00:00 - Introduction: The 70% Skincare Failure Rate 01:35 - Biome Labs: Sequencing Your Skin Microbiome at Retail 06:10 - CES 2026: Ambient AI & Tracking Cognitive Decline 08:15 - Mira Ultra 4: Clinical-Grade Hormone Tracking at Home 09:20 - Edge Computing: The Antidote to the Surveillance State 11:45 - Wearable Robotics & Neuroplasticity (FinSTIM, VR Therapy) 15:55 - InCosmetics Expo: Precision Fermentation & Upcycled Beauty 18:20 - The Regulatory Hammer: EUDR, PFAS, and the Future of Sourcing 20:40 - Conclusion: Will AI Erase Human Intuition? 📈 Tags & Keywords: HealthTech, BeautyTech, Microbiome, Ambient AI, Edge Computing, Precision Fermentation, Synthetic Biology, CES 2026, Wearable Robotics, Neuroplasticity, Longevity, Biotech Startups. REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

2. 

   1 Mar 2026

   Is Your Moisturizer Legal?

   Inside the "Invisible Fortress" of Cosmetic Regulation Pick up the nearest bottle of lotion. It looks innocent enough, promising hydration and youth. But peel back the label, and you aren't holding a cosmetic—you are holding a massive, invisible fortress of data. In this episode of REGAIA, we initiate the "Regia Protocol" to surgically dissect the European Union's cosmetic regulation (1223/2009), the gold standard for safety worldwide. Forget the misconception that you can just mix organic lavender in your kitchen and sell it. Without a Product Information File (PIF), your product is just "illegal goo." We unpack the high-stakes math of safety: from the "NOAEL" (No Observed Adverse Effect Level) to the critical Margin of Safety (MoS) calculation that determines if a product lives or dies. Discover why "natural" ingredients are often a regulatory nightmare compared to synthetics, and how the industry has moved from animal testing to sci-fi solutions like lab-grown human skin and AI predictive toxicology. The PIF (Product Information File): Why this living dossier is the passport for any cosmetic product, split into the raw data (Part A) and the critical safety verdict (Part B). The Safety Assessor: The only person legally allowed to sign off on a product's safety—and why they carry personal liability if something goes wrong. The Math of Safety (MoS): Understanding the 100x safety buffer required between toxic levels and what actually touches a consumer's skin. The "Natural" Trap: Why organic ingredients like lavender oil are chemical chaos (impurities, heavy metals) compared to the consistency of synthetics. Lab-Grown Skin & AI: How the industry replaced animal testing with reconstructed human tissue and "in silico" computer modeling to predict toxicity before a chemical is even made. Global Fracture: The nightmare of navigating conflicting regulations (EU vs. US MoCRA vs. China), where a compliant formula in one region is illegal in another. We are entering an era where human cognition alone may no longer be enough to track the impurities of impurities across a fractured global market. Will the next safety assessor need to be part toxicologist, part AI data scientist? 00:00 - The Invisible Fortress of Data 02:35 - The PIF: Part A (Evidence) vs. Part B (Verdict) 04:30 - The Safety Assessor: Personal Liability & Gatekeeping 06:15 - The Math: NOAEL and the 100x Margin of Safety 08:30 - Why "Natural" Ingredients are Regulatory Nightmares 11:40 - Nanomaterials: When Physics Changes at Scale 13:15 - Beyond Animal Testing: Lab-Grown Skin & AI Models 15:45 - The Global Regulatory Fracture (EU vs. US MoCRA) 18:30 - Conclusion: The Future of Safety Assessment Cosmetic Regulation, EU 1223/2009, Safety Assessment, Toxicology, MoCRA, Natural Cosmetics, Nanomaterials, Lab-Grown Skin, AI in Cosmetics, Regulatory Affairs. REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

3. 

   22 Feb 2026

   Cultivated Meat in Europe: The Valley of Death and the "Culinary Museum" Risk

   May 15, 1997. This date is the "hard line in the sand" that splits the European food universe into two eras. If your food wasn't consumed significantly in the EU before this date, it is legally a "Novel Food," and you are about to step into a regulatory gauntlet. In this episode of REGAIA, we dissect the EU Regulation 2015/2283 and why it poses an existential threat to FoodTech innovation (cultivated meat, precision fermentation). While the US and Singapore race ahead, Europe is paralyzed by the "Precautionary Principle" and a political culture war. We explore the "Valley of Death"—the excruciating gap between funding and approval where startups die waiting for EFSA's clock to restart. Discover why Italy banned lab-grown meat to protect "culinary heritage," why Poland is quietly funding it, and how French startup Gourmet (cultivated foie gras) is stress-testing the entire system. The 1997 Cut-Off: Understanding the legal definition of "Novel Food" and why it forces startups into a years-long approval process. The "Valley of Death": The financial reality of EFSA's "clock stop" mechanism, which can turn a 9-month theoretical timeline into a 30-month ordeal. Data Protection as a Moat: Why Article 26 (5 years of market exclusivity) is the only reason VCs still invest in European food tech. The Political Fracture: Italy's ban vs. Poland's investment. How "Food Sovereignty" is becoming a proxy for blocking innovation. The Sequenced Strategy: Why smart companies launch in Singapore or the US first to generate revenue and real-world safety data before tackling the EU fortress. The Culinary Museum Risk: Is Europe regulating itself into becoming a historical theme park while the rest of the world defines the future of food? 00:00 - The 1997 "Novel Food" Line in the Sand 02:30 - The 10 Categories & Cultivated Meat 04:15 - Data Protection (Article 26): The 5-Year Monopoly 05:45 - The "Valley of Death" & EFSA Clock Stops 07:00 - Italy's Ban & The "Food Sovereignty" War 08:50 - Poland's Counter-Strategy & The Gourmet Foie Gras Case 10:40 - The Survival Guide: Launching Outside the EU First 12:30 - Conclusion: Museum or Leader? Novel Food Regulation, Cultivated Meat, FoodTech, EU Regulatory Affairs, EFSA, Precautionary Principle, Lab-Grown Meat, Food Sovereignty, Biotech Innovation. REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

4. 

   15 Feb 2026

   Why the FDA is Turning to AI (and Why You Should Too)

   We have officially hit the 2026 regulatory bottleneck. The sheer volume of new compliance rules—from the EU MDR and the AI Act to the FDA's new QMSR and MoCRA for cosmetics—has mathematically exceeded human processing capacity. The old strategy of simply "hiring more people" is completely dead: the talent pool is shrinking, burnout sits at 42%, and Notified Body review times now stretch up to an agonizing 18 months. Even the FDA has tacitly admitted the system is broken by launching "Project Elsa," their own internal AI tool built to handle the insurmountable backlog of documents. The message is clear: if the referee is using AI just to keep up with the game, the players have no other choice. Discover why the future of compliance does not belong to passive chatbots, but to "Agentic AI." These are active, autonomous systems that cross-reference your technical files against thousands of ISO standards to flag critical discrepancies before a human even sees them. It is the ultimate shift from manual data gathering to strategic verification. The Exponential Web of Rules: How changing a single line of code in a smart device triggers a massive cascade of compliance updates across the MDR, GDPR, and the EU AI Act. The Hiring Illusion: Why you cannot hustle your way out of this crisis. There is a deep structural shortage of talent, with only 552 new regulatory Master's graduates facing an industry where 20% of experts are aging out. The MoCRA Shock: Nearly half (48%) of imported cosmetics fail the new U.S. standards, risking massive recalls that can cost a manufacturer up to $600 million and fatal market delays. Agentic AI Workflows: The critical difference between asking an AI a question and deploying an agent to audit a dossier, cutting routine documentary tasks by 80% while keeping a human in the loop for final sign-off. The Mid-Size Moat: Why agile, mid-sized firms have a unique window to outpace slow-moving industry giants by training AI agents on their own proprietary historical data. When the regulatory water is rising faster than you can run, the only viable choice is to build a boat. In an industry that now moves at the speed of software, will your company upgrade its operating system, or be swept under the paperwork tsunami? 00:00 - The "Documentary Tsunami" and the 2026 Bottleneck 02:00 - Exponential vs. Linear Regulatory Inflation 04:30 - Deadlines and the Notified Body Crisis (18-Month Delays) 06:45 - The Cosmetics Crisis (MoCRA) and the $600M Cost of Recalls 08:30 - The Unsolvable Math of Hiring & Industry Burnout 09:45 - Project Elsa: The FDA's Official Shift to AI 11:20 - Agentic AI vs. Chatbots: An 80% Productivity Leap 13:20 - How Mid-Size Firms Can Build an AI Competitive Moat Regulatory Affairs, Agentic AI, FDA, EU MDR, MoCRA, Compliance, Medical Devices, Cosmetics Regulation, Project Elsa, Artificial Intelligence, Future of Work, Quality Management System. REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

5. 

   9 Feb 2026

   The Phosphate Paradox: Why Your DNA Needs It, But Your Kidneys Hate It (E450 Deep Dive)

   Is the back of a food package a battlefield? When it comes to Phosphates, absolutely. 🥓 It is the literal backbone of your DNA and the fuel for your muscles (ATP), yet the wellness community calls it a toxin and the EFSA has placed it under strict surveillance. In this deep dive, we navigate the massive biological paradox of Phosphates. From 19th-century chemistry to the modern deli counter, we explain why food scientists view inorganic phosphates (E450) as a "magic wand" for texture, while nephrologists view them as a threat. Why does a slice of ham need phosphates to hold together? Why do inorganic additives spike your blood levels significantly more than natural foods? And why are teenagers and supplement takers most at risk of "turning soft tissue into stone"? 🎙️ Key Takeaways: • The Biological Paradox: Understanding how the molecule that powers every thought and muscle contraction (ATP) became one of the most contentious ingredients on the market. • The "Glassy Solid" Discovery: How Berzelius’s accidental creation of inorganic polymers paved the way for industrial food texturizing (from detergents to sausages). • The "Molecular Key" in Meat: The specific chemistry of how Diphosphates unlock the actin-myosin complex in dead muscle, allowing processed meat to retain water and remain sliceable (it's not just about cheap fillers). • The Bioavailability Trap: The critical data point: Your body absorbs only 50-60% of organic phosphates (steak/beans), but absorbs 90% of inorganic additives (sodas/processed meat), creating a dangerous spike. • The EFSA 2019 Warning: Analysis of the European Food Safety Authority’s re-evaluation, the risk of vascular calcification (kidney damage), and the tight Acceptable Daily Intake (ADI) of 40mg/kg that many modern diets are breaching. 💡 The Final Thought: We engineered a form of phosphate that enters our system faster and harder than nature ever intended. The future of food regulation isn't just about banning additives, but assessing the "Total Load" on our kidneys. Phosphates, E450, Food Additives, Clean Label, Kidney Health, EFSA, Processed Meat, Bioavailability, Food Science, Regulatory Affairs, Nutrition. REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

6. 

   6 Feb 2026

   The "SaaSpocalypse" Warning: Why the $300B Legal Tech Crash is a Crystal Ball for MedTech

   Friday, February 6, 2026. The dust has not settled. 📉 Just three days ago, the market blinked, and $300 billion in market cap evaporated from giants like Thomson Reuters. The cause wasn't a war or a pandemic—it was a simple software plugin from Anthropic. In this deep dive, we explore why this "blood bath" in legal tech is actually a massive signal for Regulatory Affairs professionals (MedTech, Pharma, Cosmetics). We are witnessing the death of "Conversational AI" (the smart encyclopedia) and the birth of "Agentic AI" (the junior specialist). Discover how the FDA is already using this tech (Project ELSA) to handle the staffing crisis, and why the new Model Context Protocol (MCP) finally solves the data security nightmare. Stop asking chatbots questions; start delegating tasks. 🎙️ Key Takeaways (SEO & GEO Optimized): The "Suspocalypse" Explained: Analyzing the February 3, 2026 market crash where a simple legal plugin disrupted a multi-billion dollar industry overnight. Conversational vs. Agentic AI: Understanding the paradigm shift from asking an AI ("Is this compliant?") to delegating a task ("Review this dossier against EU MDR Annex 2 and generate the report"). The 3 Enablers of Trust: How MCP (the "USB for AI"), Sandboxed Environments (the "Vault"), and Configurable Playbooks (encoded tacit knowledge) make AI safe for regulated industries. The FDA is Already There: Revealing Project ELSA, the internal generative AI system the FDA uses to cope with a 15% staffing shortage while device submissions skyrocket. The 5 Capabilities of an Agent: Why true Agentic AI must handle multi-step workflows, tool integration, file creation, iterative reasoning, and—crucially—audit trails. 💡 The Final Thought: The era of the "Document Compiler" is over. To survive the AI transition, you must evolve into a "Compliance Architect"—managing the agents that do the groundwork. REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

7. 

   3 Feb 2026

   The "SaaSpocalypse" of 2026: When Agentic AI Crushed the Legal Giants (and Why MedTech is Next)

   February 3, 2026: The day $300 billion vanished from the software market. 📉 It wasn't a pandemic or a geopolitical crisis. It was a software plugin. In this episode, we dissect the "Suspocalypse," a market-shattering event where giants like Thomson Reuters and RELX plunged ~15% in a single morning. The cause? Anthropic's release of Claude Cowork, which proved that AI workflows are no longer a product you can sell, but a free feature of the model itself. We analyze the death of the "Wrapper" business model (goodbye, Harvey AI) and bridge the gap to the Regulatory Affairs industry. If you are drowning in EU MDR paperwork or spiraling FDA costs, this episode is your wake-up call. Discover the shift from "Conversational AI" (the recipe) to "Agentic AI" (the private chef), and how the new Model Context Protocol (MCP) finally solves the security nightmare, allowing AI to audit your proprietary data without leaking it. 🎙️ Key Takeaways (SEO & GEO Optimized): The "Suspocalypse" Explained: Analysis of the Feb 3, 2026 crash where legacy data fortresses (Thomson Reuters, Wolters Kluwer) lost their "moat" against open-source AI plugins. The Death of the "Wrapper": Why startups like Harvey AI (valued at $8B) were rendered obsolete by 5 simple slash commands from Anthropic. Agentic AI vs. Chatbots: Understanding the "Chef Analogy": why we are moving from an AI that gives instructions to an AI that executes tasks (audits, gap analysis) autonomously. The Regulatory Bottleneck: Addressing the EU MDR crisis, where bringing a standard 510(k) device to market now costs $31M, and how AI Agents are the only scalable solution. The Security Breakthrough (MCP): How the Model Context Protocol acts as a "USB port for AI," allowing agents to securely access internal firewalled data without uploading it to the public cloud. Strategic Pivot: Why your old PDFs and rejected submissions are no longer trash, but the "Golden Training Data" that will define your firm's future value. 💡 The Final Thought: If an AI Agent can do three weeks of compliance work in 10 minutes, the question isn't "Will I lose my job?", but "Am I ready to become the architect who manages the Agents?" REGAIA — REGulatory AI Agents is the podcast for regulatory affairs professionals navigating the AI revolution. AI agents are reshaping regulatory compliance. REGAIA decodes the disruption for medical devices, cosmetics & beyond. From the $300 billion legal tech crash to the rise of autonomous compliance agents, REGAIA delivers data-driven analysis, strategic frameworks, and actionable intelligence for: • Quality & Regulatory Affairs Directors • Compliance Consultants & Consulting Firm Leaders • HealthTech & BeautyTech Entrepreneurs • RegTech Innovators & Investors Whether you're a regulatory consultant protecting your practice or an entrepreneur building the next generation of compliance tools, REGAIA gives you the intelligence edge. New episodes every week. Stay compliant. Stay ahead. Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.

Contact REGAIA - REGulatory AI Agents - The compliance podcast

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.